LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 51 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,000 | -99.9% | 10,000 | -99.9% | 0.00% | -100.0% |
| Q2 2021 | $14,802,000 | -71.7% | 15,000,000 | -70.3% | 0.29% | -74.5% |
| Q1 2021 | $52,330,000 | +3.1% | 50,581,000 | -5.4% | 1.13% | +4.3% |
| Q4 2020 | $50,779,000 | -0.5% | 53,485,000 | -4.8% | 1.08% | -3.8% |
| Q3 2020 | $51,013,000 | +92.0% | 56,178,000 | +84.2% | 1.12% | +80.6% |
| Q2 2020 | $26,576,000 | +539.8% | 30,500,000 | +510.0% | 0.62% | +592.2% |
| Q1 2020 | $4,154,000 | -92.1% | 5,000,000 | -91.8% | 0.09% | -91.2% |
| Q4 2019 | $52,832,000 | +0.3% | 60,954,000 | -3.4% | 1.02% | +3.6% |
| Q3 2019 | $52,698,000 | -10.2% | 63,124,000 | -7.1% | 0.99% | -13.0% |
| Q2 2019 | $58,675,000 | – | 67,972,000 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 70,062,000 | $61,167,000 | 7.51% |
| SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $15,668,000 | 5.06% |
| Context Capital Management, LLC | 6,350,000 | $5,569,000 | 2.17% |
| CANYON CAPITAL ADVISORS LLC | 60,000,000 | $52,680,000 | 1.76% |
| Opti Capital Management, LP | 8,500 | $7,400,000 | 1.26% |
| III Capital Management | 5,000,000 | $4,365,000 | 1.08% |
| FALCON POINT CAPITAL, LLC | 250,000 | $219,000 | 1.07% |
| Venator Capital Management Ltd. | 1,500,000 | $1,308,000 | 0.86% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 30,500,000 | $26,576,000 | 0.62% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,733,000 | 0.48% |